Drug Research
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use Disorder
KemPharm, Inc. , a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced the addition of a new product candidate,...
Press Releases
PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies
PANTHERxยฎ Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroadsย by McKesson, the leading commercial solutions partner for life sciences companies, announced their...
Drug Research
PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies
PANTHERxยฎ Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroadsย by McKesson, the leading commercial solutions partner for life sciences companies, announced their...
Press Releases
New Analyses on Mortality from the 18,924-Patient ODYSSEY OUTCOMES Trial
Regeneron Pharmaceuticals, Inc. and Sanofi announced that new analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association...
Clinical Trials
AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV
AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the Phase III MYSTIC trial. ...
Research Insight
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of ยฃ2.5 million from existing investors and company management. The investment...
Press Releases
Quanticate Sponsors Research into Response Adaptive Trial Design
Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















